<DOC>
	<DOCNO>NCT01619956</DOCNO>
	<brief_summary>The osteotome sinus floor elevation ( OSFE ) technique prove predictable procedure successful implant placement posterior maxilla limit bone height sinus . OSFE consider minimal invasive minimal traumatic limitation regard residual bone height . According consensus conference 1996 , OSFE technique without bone grafting limit RBH range 7mm 9mm . However , recent study report favorable result even RBH around 4mm . Moreover , still controversy regard necessity graft material order maintain space new bone formation . Spontaneous bone formation observe OSFE without graft research . Due lack randomize control trial ( RCTs ) , still clear guideline implant therapy posterior maxilla limit bone height . Neither evidence recommend contraindicate application graft material combination OSFE . The present RCT aim evaluate clinical success OSFE RBH 2mm 6 mm study whether application graft material combination OSFE favorable . The hypothesis application simultaneous graft significant advantage term clinical success . Spontaneous bone formation observe implant place use OSFE without graft . 90 systemically healthy adult consecutively admit oral implant therapy randomly assign 3 test group . Only one implant system use minimize implant-originated influencing factor . Bio-Oss® chosen bone substitute currently typical xenograft available . Autogenous bone also use deem 'gold standard ' bone graft material . A panoramic radiograph intra-oral radiograph take assess pretreatment bone height sinus . For T1 group , autogenous bone chip harvest drilling procedure mixed Bio-Oss® . And mixture place 'socket ' osteotomes elevate sinus membrane final depth . For T2 group , Bio-Oss® place 'socket ' osteotomes elevate sinus membrane final depth . No graft material use T3 group . The subject recall follow-up visit 3 month , 6 month , 1 year , 2 year 3 year surgery clinical radiographic examination . Implant protrusion length , endo-sinus bone gain crestal bone level measure radiographs use specialized software . ANOVA perform success rate 3 group . Descriptive statistic use radiographic parameter . The present study aim provide preliminary evidence important clinical question whether OSFE predictable reliable RBH le 6mm whether application graft material necessary indication .</brief_summary>
	<brief_title>Osteotome Sinus Floor Elevation With Without Grafting</brief_title>
	<detailed_description>1 . Specific aim 1 . To evaluate clinical success implant place posterior maxilla limit residual bone height ( 2mm 6 mm ) use OSFE without simultaneous graft 2 . To study influence simultaneous graft clinical success dental implant posterior maxilla use OSFE 3 . To observe bone change elevate space sinus without graft . The null hypothesis application simultaneous graft significant advantage term clinical success . Spontaneous bone formation observe implant place use OSFE without graft . 2 . Background significance Posterior maxilla commonly pose challenge successful dental implant due poor bone quality insufficient bone quantity . Efforts make allow successful implant placement posterior maxilla subject limit bone height sinus . Approaches available include application tilt implant , short implant , sinus floor elevation technique , etc . The osteotome sinus floor elevation ( OSFE ) technique , first introduce Tatum 1986 , prove predictable procedure . For OSFE , access sinus membrane achieve crestal approach . Therefore , compare window technique , OSFE consider less invasive less traumatic limitation regard residual bone height . According consensus conference 1996 , OSFE technique limit RBH range 7mm 9mm . However , improvement implant design surgical technique , high predictability implant therapy encourage re-evaluation limitation . Favorable result report compromised site even RBH around 4mm . Moreover , controversy regard necessity graft material order maintain space new bone formation . In previous pilot study , 42 implant place posterior maxilla OSFE without bone grafting material . The RBH range 4mm 8mm ( average 6.36mm ) . The 5-month result also demonstrate predictable result . But date , still insufficient data regard clinical result implant posterior maxilla OSFE technique without graft still remain elucidated necessity graft OSFE . And lack well-designed RCTs make level evidence relatively low . In context , therefore , applicant attempt assess clinical success dental implant place posterior maxilla use OSFE without graft observe endo-sinus bone change specially RBH 2mm 6 mm . C. Methods Randomization Subjects allocate three test group use random number table . Allocation equalize every 15 case . One research assistant perform randomization . Study visit procedure Pretreatment Assessment ( Baseline ) History-taking consent taking : A detailed examination take make sure subject fulfill inclusion criterion . The subject read sign consent form . Examination : A detailed dental examination perform assess intend implant site , include dimension edentulous site , status mucosa status adjacent teeth . Baseline : A panoramic radiograph intra-oral radiograph take assess pretreatment bone height sinus . Surgical procedure ( Surgical Day ) : Local infiltration anesthesia use subject . A midcrestal incision , mesial distal release incision extend well buccal fold perform full-thickness muco-periosteal flap reflect . A round bur ( Φ2.3 mm ) first use mark implant position . Then , minimal pilot drilling ( Φ2.2mm ) perform depth approximately1 mm away sinus floor boundary accord depth take panoramic radiograph CT scan . The cortical part implant bed widen either Φ3.5mm forΦ4.1mm implant Φ 4.2mm Φ4.8mm implant . At stage , integrity sinus membrane examine use Valsava manoeuvre . Then elevation maxillary sinus achieve use Φ2.8mm osteotome light malleting achieve initial sinus upfracture develop osteotomes increase diameter gradually till final depth . For group1 , autogenous bone chip harvest drilling procedure mixed Bio- Oss® . And mixture place 'socket ' osteotomes elevate sinus membrane final depth . No graft material use group2 . No profile drill use case . The implant place prepared osteotomy site use hand ratchet without tap . All implant place site use nonsubmerged technique one stage procedure . Postoperative treatment Anti-inflammatory cefradine ( Xinya Co. , Shanghai , China , 500mg , 4 time day 7 day ) metronidazole ( Xinyiwanxiang , Shanghai , China , 400mg , 3 time day 7 day ) use . Nonsteroidal anti-inflammatory agent prescribe post-surgical analgesia . 0.12 % chlorhexidine oral rinse prescribe 60 second 5-6 time day 14 day . Sutures remove 1 week . Patients allow use removable prosthesis heal period . Patients avoid blow nose healing period . Prosthetic Procedure ( Prosthetic Day ) The implant allow heal 6 month . Porcelain-fused-to-gold prosthesis attach implant 7 10 day impression take . Follow-ups The subject recall follow-up visit 3 month , 6 month , 1 year , 2 year 3 year surgery clinical radiographic examination . Parameters examine Radiographic parameter : 1 . Baseline : Pretreatment bone height sinus implant site ( mesial distal ) 2 . Surgical Day : Implant protrusion length ( mesial distal ) 3 . Prosthetic Day Follow-ups : Endo-sinus bone gain ( mesial distal ) 4 . Prosthetic Day Follow-ups : Crestal bone level ( mesial distal ) Clinical parameter : 1 . Surgical day : Schneiderian membrane integrity 2 . Follow-ups : Post-operative complication ( e.g . nose bleeding , infection ) 3 . Follow-ups : Implant mobility 4 . Follow-ups : Probing depth Data collection Radiographic data : A panoramic intra-oral radiograph take follow-up visit . For intra-oral radiograph , parallel technique apply . One experienced staff department radiology responsible take radiograph . The parameter measure use specialize software . Clinical data : Dr. Huan-Huan Jiang Dr. Shi-Chong Qiao , blind group subject belong , responsible clinical data collection . Statistical analysis ANOVA perform success rate 3 group . The criterion significance set α=0.05 β=0.20 . The ANOVA non-directional . Descriptive statistic use radiographic parameter .</detailed_description>
	<criteria>Age ≥ 18 year partial edentulism maxillary posterior region least 6 month tooth loss residual bone height range 2mm 8mm ( measure presurgical radiograph ) sufficient bone width edentulous region systemic local condition compatible implant placement sinus floor elevation willing provide inform consent capable comply study protocol . uncontrolled diabetes mellitus systemic disorder uncontrolled periodontal condition , endodontic lesion oral disorder heavy smoker ( ≥ 10 cigarette per day ) rhinitis sinusitis insufficient residual bone quality achieve implant stability previous implant installation bone graft surgical site</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>dental implant</keyword>
	<keyword>osteotome sinus floor elevation</keyword>
	<keyword>survival rate</keyword>
	<keyword>sinus graft</keyword>
	<keyword>bone remodel</keyword>
	<keyword>RCT</keyword>
	<keyword>radiographic analysis</keyword>
</DOC>